AML cell lines overexpressing these proteins released less Ca2+ after venetoclax treatment, suggesting that the S100A8/A9 complex may mediate resistance in AML by hindering the migration of Ca2+ toward the mitochondrion and subsequently inhibiting apoptosis. This evidence concerns the gene IGKV1D-22 and acute myeloid leukemia.